Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Wed Sep 8 2010 NZST

RSSRSS feed (help and list of feeds)

GP Newsletter

Page updated on 02 Sep 2010


Linked documents

page1

2010-09 GP Newsletter (2 pages, 99 KB)
Pharmaceutical Management Agency GP Newsletter Sept 2010 Wholesale Supply Orders – Please note, these no longer exist. For all spacer (and other products previously available via WSO) orders, please order via a PSO through your local pharmacy. Please note these…

text


page1

2010-08 GP Newsletter (2 pages, 98 KB)
Pharmaceutical Management Agency GP Newsletter PHARMAC Schedule Changes July 2010 Topical acne treatment subsidised July 2010 ReTrieve (tretinoin) cream (0.5 mg per g), 50 g will be fully subsidised from 1 July 2010. ReTrieve will have a maximum subsidised quantity…

text


page1

2010-07 GP Newsletter (2 pages, 98 KB)
Pharmaceutical Management Agency GP Newsletter PHARMAC Schedule Changes July 2010 Topical acne treatment subsidised July 2010 ReTrieve (tretinoin) cream (0.5 mg per g), 50 g will be fully subsidised from 1 July 2010. ReTrieve will have a maximum subsidised quantity…

text


page1

2010-06 GP Newsletter (1 page, 63 KB)
Pharmaceutical Management Agency PHO Newsletter Tramadol hydrochloride – new listing June 2010 From 1 June 2010, Arrow-Tramadol (tramadol hydrochloride) 50 mg capsules will be subsidised without restriction on the Pharmaceutical Schedule. This treatment for acute and chronic pain will help…

text


page1

2010-05 GP Newsletter (1 page, 61 KB)
Pharmaceutical Management Agency PHO Newsletter Prazosin hydrochloride – out of stock May 2010 PHARMAC has been advised that the current supplier of prazosin hydrochloride tablets in New Zealand, Apotex NZ Ltd, is running short of stock of the 1 mg…

text


page1

2010-04 GP Newsletter (1 page, 64 KB)
Pharmaceutical Management Agency PHO Newsletter Travoprost – reference pricing April 2010 From 1 April 2010 the subsidy for travoprost (Travatan) eye drops 0.004% has reduced to match that of latanoprost eye drops 50 μg per ml, 2.5.ml (Hysite). This will…

text


page1

2010-03 GP Newsletter (2 pages, 62 KB)
Pharmaceutical Management Agency PHO Newsletter Aromatase inhibitors There are some changes to the subsidises for aromatase inhibitors. In summary: March 2010 Anastrozole • Both DP-Anastrozole and Arimidex brands will remain fully funded from 1 February 2010. Arimidex remains fully funded…

text


page1

2010-02 GP Newsletter (1 page, 56 KB)
Pharmaceutical Management Agency PHO Newsletter Aromatase inhibitors – reference pricing February 2010 There are some changes to the subsidies of the aromatase inhibitors – anastrozole, letrozole and exemestane. These changes include the listing of a new brand of letrozole, as…

text


page1

2010-01 GP Newsletter (1 page, 66 KB)
Pharmaceutical Management Agency PHO Newsletter There are three new medicines listed from 1 January 2010 January 2010 Recent Pharmaceutical Schedule Changes Solifenacin succinate (Vesicare) 5 mg and 10 mg tablets will be listed with Special Authority criteria. It provides a…

text


page1

2009-12 GP Newsletter (1 page, 66 KB)
Pharmaceutical Management Agency PHO Newsletter Diclofenac sodium – new brands listed December 2009 Recent Pharmaceutical Schedule Changes Apotex’s diclofenac sodium long-acting 75 mg and 100 mg tablets (Apo-Diclo SR) are currently out of stock. PHARMAC has listed two alternate brands…

text


page1

2009-11 GP Newsletter (1 page, 65 KB)
Pharmaceutical Management Agency PHO Newsletter Mirtazapine – new listing November 2009 Recent Pharmaceutical Schedule Changes The antidepressant mirtazapine (Avanza) will be subsidised from 1 November 2009. Mirtazapine tablets will be subsidised subject to Special Authority criteria. See page 14 of…

text


page1

2009-10 GP Newsletter (1 page, 68 KB)
Pharmaceutical Management Agency PHO Newsletter Clarithromycin for helicobacter pylori eradication October 2009 Recent Pharmaceutical Schedule Changes A new strength of clarithromycin 500 mg tablets will be subsidised from 1 October 2009 specifically for use in the treatment of helicobacter pylori…

text


page1

2009-09 GP Newsletter (1 page, 95 KB)
Pharmaceutical Management Agency PHO Newsletter Nicotine Replacement Therapy – available on prescription September 2009 Recent Pharmaceutical Schedule Changes Nicotine replacement therapy (NRT) will be subsidised on either a prescription or a Quit Card from 1 September 2009. This means prescribers…

text


page1

2009-08 GP Newsletter (1 page, 95 KB)
Pharmaceutical Management Agency PHO Newsletter Enoxaparin sodium - new listings August 2009 Recent Pharmaceutical Schedule Changes The low molecular weight heparin Clexane injection (enoxaparin sodium) will be listed on the Pharmaceutical Schedule under Special Authority criteria from 1 August 2009.…

text


page1

2009-07 GP Newsletter (1 page, 97 KB)
Pharmaceutical Management Agency PHO Newsletter Methylphenidate - new listings July 2009 Recent Pharmaceutical Schedule Changes The Ritalin, Ritalin SR and Ritalin LA brands of the Attention Deficit/Hyperactivity Disorder (ADHD) treatment methylphenidate hydrochloride will be fully subsidised subject to Special Authority…

text


page1

2009-06 GP Newsletter (1 page, 135 KB)
Pharmaceutical Management Agency PHO Newsletter Pharmaceutical Omeprazole Simvastatin Paracetamol Only Fully Subsidised Brand Dr Reddys Omeprazole Arrow-Simva (from August) Pharmacare Paracetamol June 2009 Recent Pharmaceutical Schedule Changes Brand that is no longer Subsidised Losec Lipex (from August) Panadol Metoprolol succinate…

text